BEAU MUHLBACH: Open Payments
NPI 1841792710 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 6 companies in 2025. Trend: 2023 $44 · 2024 $38 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| PFIZER INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: JARDIANCE, VERQUVO, REPATHA, ELIQUIS, LEQVIO, NEXLETOL.
Industry payments across TX — which companies pay providers there.
